Moxonidine 0.2 mg + Amlodipine 5 mg Tablet – Manufacturer, Supplier & PCD Franchise
Moxonidine 0.2 mg + Amlodipine 5 mg Tablet
Moxonidine 0.2 mg + Amlodipine 5 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Centrally acting antihypertensive + Dihydropyridine calcium channel blocker
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Moxonidine 0.2 mg + Amlodipine 5 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Essential (primary) hypertension
- Hypertension not controlled on a single agent, in combination therapy
- Hypertension, alone or with other antihypertensives
- Chronic stable angina
Mechanism of Action
Moxonidine — Moxonidine selectively stimulates imidazoline I1 receptors in the brainstem, reducing sympathetic nervous outflow. This lowers peripheral vascular resistance and blood pressure, with fewer sedative effects than older centrally acting agents.
Amlodipine — Blocks L-type calcium channels in vascular smooth muscle, causing arterial dilation that lowers blood pressure and reduces cardiac workload and anginal episodes.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Moxonidine 0.2 mg + Amlodipine 5 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Dry mouth
- Dizziness
- Drowsiness or fatigue
- Ankle swelling (pedal oedema)
- Headache
- Flushing
Contraindications
- Known hypersensitivity to any component of the formulation
- Sick sinus syndrome, marked bradycardia or second/third-degree heart block
- Heart failure
- Severe hypotension or cardiogenic shock
- Severe aortic stenosis
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the top cardiac-diabetic PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
See the full cardiac tablets range – manufacturer, supplier and PCD franchise: telmisartan, olmesartan, amlodipine, metoprolol, rosuvastatin, atorvastatin, clopidogrel, ticagrelor, trimetazidine and their combinations.
PCD Pharma Franchise & Third Party Manufacturing — Moxonidine + Amlodipine Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Moxonidine 0.2 mg + Amlodipine 5 mg. It is a fixed-dose combination of centrally acting antihypertensive and dihydropyridine calcium channel blocker, used for essential (primary) hypertension and hypertension, alone or with other antihypertensives. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Moxonidine + Amlodipine Tablet brings together Moxonidine (centrally acting antihypertensive) and Amlodipine (dihydropyridine calcium channel blocker) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Moxonidine + Amlodipine Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Moxonidine + Amlodipine Tablet in India?
Trumac Healthcare is a supplier of Moxonidine + Amlodipine Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Moxonidine + Amlodipine Tablet used for?
Moxonidine + Amlodipine Tablet is used for essential (primary) hypertension; hypertension not controlled on a single agent, in combination therapy; hypertension, alone or with other antihypertensives; chronic stable angina. It should be used as advised by a registered medical practitioner.
Is Moxonidine + Amlodipine Tablet available for PCD pharma franchise on monopoly basis?
Yes. Moxonidine 0.2 mg + Amlodipine 5 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Moxonidine + Amlodipine for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Moxonidine + Amlodipine Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Moxonidine + Amlodipine Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Moxonidine + Amlodipine?
Moxonidine + Amlodipine is a fixed-dose combination of centrally acting antihypertensive and dihydropyridine calcium channel blocker (therapeutic class: Fixed-Dose Combination — Centrally acting antihypertensive + Dihydropyridine calcium channel blocker).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Moxonidine + Amlodipine Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Moxonidine 0.2 mg + Amlodipine 5 mg Tablet?
